Medical Condition

ulcerative colitis

Total Trials

19

Recruiting Now

19

Trial Phases

Phase 3, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for ulcerative colitis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — ulcerative colitis Clinical Trials

How many clinical trials are currently recruiting for ulcerative colitis?

ClinicalMetric currently tracks 19 actively recruiting clinical trials for ulcerative colitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for ulcerative colitis?

ulcerative colitis research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a ulcerative colitis clinical trial?

Eligibility criteria for ulcerative colitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Xijing Hospital 2 trials

Pfizer 2 trials

University of Zimbabwe 1 trial

Takeda 1 trial

Alfasigma S.p.A. 1 trial

ulcerative colitis

Frequently Asked Questions — ulcerative colitis Clinical Trials

Recruiting Clinical Trials

IBD Registry in a Sub-Saharan African Population

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Immune Regulation in Ulcerative Colitis or Crohn s Disease

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

Combination of Diet and Oral Budesonide for Ulcerative Colitis

Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.

Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

IBD Strong Peer2Peer for Self-Management of Psychological Distress

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

Predictors of Prognosis in IBD Patients

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy